The agreement’s limit is 400,000 shares or 9.3 percent of the 4,311,112 shares currently outstanding.
SpineGuard has the sole discretion to determine the timing of the funding. While the agreement secures the company’s financial resources, it does not reflect an immediate need for cash.
More Articles on Devices:
SCOTUS Reverses Medtronic Patent Infringement Decision, Sides With Device Company
MicroPort Scientific to Build Training Facility for Orthopedic Business
Orthofix Names Kathleen Regan as Interim Board Chairman
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
